Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Technologies Scan Corp
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Technologies Scan Corp
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Technologies Scan Corp
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
$
PETV
Technologies Scan Corp
CIK:
0001512922
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]
Revenues
$ 337,572
$ 297,500
Cost of Sales
114,255
110,774
Gross Profit
223,317
186,726
Operating Expenses:
Sales and Marketing
631,305
621,712
Research and Development
233,419
340,513
General and Administrative
967,442
1,068,818
Total Operating Expenses
1,832,166
2,031,043
Operating Loss
(1,608,849)
(1,844,317)
Other Income (Expense)
Loss on Disposal of Assets
(149,125)
Unrealized Loss on Change in Derivative Liabilities
(320,404)
Other Income
111,518
Interest Income
13,099
Interest expense
(5,039)
(121,808)
Total Other Income (Expense)
(5,039)
(466,720)
Loss before taxes
(1,613,888)
(2,311,037)
Income Tax Provision
Net Loss
(1,613,888)
(2,311,037)
Less: Series B Preferred Stock Dividends
(125,000)
(28,603)
Net Loss Available to Common Stockholders
$ (1,738,888)
$ (2,339,640)
Net Loss Per Share:
Basic
$ (0.05)
$ (0.10)
Diluted
$ (0.05)
$ (0.10)
Weighted Average Common Shares Outstanding:
Basic
37,055,261
24,302,790
Diluted
37,055,261
24,302,790
v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss
$ (1,613,888)
$ (2,311,037)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Stock-based compensation
460,609
133,197
Depreciation and amortization
134,671
117,890
Amortization of Right-of-Use asset
16,057
15,722
Unrealized loss on change in fair value of derivatives
320,404
Loss on disposal of fixed assets
149,125
Amortization of debt discount
66,259
Common stock issued for services
160,000
40,420
Changes in Operating Assets and Liabilities
Prepaid expenses and other current assets
(13,330)
56,076
Accounts receivable
17,051
34,625
Inventory
87,032
(205,838)
Accounts payable and accrued expenses
(202,933)
(87,996)
Lease liabilities
(16,057)
(15,722)
Accrued interest on notes payable
5,009
53,120
Net Cash (Used In) Operating Activities
(965,779)
(1,633,755)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of equipment
(12,370)
Net Cash (Used in) Investing Activities
(12,370)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds received from common stock subscription receivable
600,000
Proceeds from issuance of common stock
150,000
Proceeds received from preferred stock subscription receivable
4,400,000
Proceeds from the issuance of convertible debentures
160,000
Proceeds from the exercise of warrants
140,000
Proceeds from the issuance of notes payable
150,000
12,000
Repayments of notes payable
(2,090)
Net Cash Provided by Financing Activities
900,000
4,709,910
Net (decrease)/increase in Cash
(78,149)
3,076,155
Cash at Beginning of Period
200,782
227,689
Cash at End of Period
122,633
3,303,844
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest
2,635
Stock granted for consulting services
161,000
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING AND INVESTING ACTIVITIES
(Decrease) increase to operating lease right of use asset and operating lease liability
(859,504)
Vesting of restricted stock units
150
Dividends declared on Series B preferred stock
125,000
Convertible debentures and accrued interest converted to common stock
301,558
Common stock issued for prepaid consulting fees
$ 160,000
v3.26.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Mar. 31, 2026
Current Assets
Cash
$ 122,633
$ 200,782
Accounts receivable, net of allowance for credit losses
83,792
100,843
Subscriptions receivable
600,000
Inventory
451,334
538,366
Prepaid expenses and other current assets
283,260
269,930
Total Current Assets
941,019
1,709,921
Property and Equipment, net
447,089
448,881
Other Assets:
Operating lease right-of-use assets
38,654
54,711
Patents and trademarks, net
20,000
20,509
Licensing Agreement, net
1,059,889
1,179,889
Investments
150,000
150,000
Security deposit
12,830
12,830
Total Other Assets
1,281,373
1,417,939
Total Assets
2,669,481
3,576,741
Current Liabilities
Accounts payable
453,291
547,421
Accrued expenses
344,911
453,713
Operating lease liabilities – current portion
38,654
54,711
Notes payable and accrued interest – current portion
476,456
321,447
Total Current Liabilities
1,313,312
1,377,292
Total Liabilities
1,313,312
1,377,292
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Common Stock, par value $0.001, 250,000,000 shares authorized, 37,594,245 and 35,849,919 issued and outstanding at June 30, 2026 and March 31, 2026, respectively
37,595
35,850
Common stock to be issued
48,000
649,750
Additional Paid-In Capital
104,316,968
102,821,355
Accumulated Deficit
(103,051,394)
(101,312,506)
Total Stockholders’ Equity
1,356,169
2,199,449
Total Liabilities and Stockholders’ Equity
2,669,481
3,576,741
Preferred Class B [Member]
Stockholders’ Equity:
Preferred stock, value
$ 5,000
$ 5,000